|
NPAT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75673999999182E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.80016999999921E-05 |
| Normal-vs-Stage2 |
1.536030E-01 |
| Normal-vs-Stage3 |
1.167580E-02 |
| Normal-vs-Stage4 |
8.16000000014583E-07 |
| Stage1-vs-Stage2 |
2.805000E-01 |
| Stage1-vs-Stage3 |
8.279400E-01 |
| Stage1-vs-Stage4 |
8.962200E-03 |
| Stage2-vs-Stage3 |
4.907400E-01 |
| Stage2-vs-Stage4 |
1.073590E-02 |
| Stage3-vs-Stage4 |
3.347700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.68039999998349E-06 |
| Normal-vs-AfricanAmerican |
3.042500E-03 |
| Normal-vs-Asian |
7.208800E-04 |
| Caucasian-vs-AfricanAmerican |
4.667600E-01 |
| Caucasian-vs-Asian |
4.299800E-01 |
| AfricanAmerican-vs-Asian |
3.070800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.39249999975277E-07 |
| Normal-vs-Female |
2.829400E-01 |
| Male-vs-Female |
9.593200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.398200E-04 |
| Normal-vs-Extreme_Weight |
3.10300000028185E-07 |
| Normal-vs-Obese |
3.304500E-02 |
| Normal-vs-Extreme_Obese |
7.8848999999992E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.020800E-01 |
| Normal_Weight-vs-Obese |
1.404980E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.192400E-01 |
| Extreme_Weight-vs-Obese |
2.271600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.609800E-01 |
| Obese-vs-Extreme_Obese |
1.180620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.173400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.463470E-03 |
| Normal-vs-Age(61-80Yrs) |
4.60089999987368E-07 |
| Normal-vs-Age(81-100Yrs) |
1.70829999999178E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.402400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.186100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.053700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.379700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.423800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.889800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.95439999994829E-06 |
| Normal-VS-Type2 PRCC |
3.11590000023898E-07 |
| Normal-VS-KIRP CIMP |
6.460400E-01 |
| Normal-VS-Unclassified PRCC |
2.981000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.483400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.134780E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.753500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.369500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.054000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.092800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.33540000016808E-07 |
| Normal-vs-N1 |
7.978500E-02 |
| Normal-vs-N2 |
3.217700E-04 |
| N0-vs-N1 |
2.616400E-01 |
| N0-vs-N2 |
3.218800E-01 |
| N1-vs-N2 |
3.368500E-02 |
|
|
